Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Nastech's intranasal apomorphine enters phase II for MED

Oct. 31, 2000

Antifibrotic agents patented by Sumitomo

Oct. 27, 2000

ASA 2000: Ono-5046 protects against I/R-induced renal injury via effect on leukocyte activation

Oct. 25, 2000

KMD-3213: binding kinetics and pharmacological activity correlated in vivo

Oct. 25, 2000

Vivus withdraws Alibra NDA

Oct. 23, 2000

New series of PDE5 inhibitors and their use described by Sanofi-Synthelabo

Oct. 19, 2000

Abbott researchers design novel water-soluble K+ channel openers

Oct. 17, 2000

Novel 5-HT reuptake inhibitors specifically claimed for use in premature ejaculation

Oct. 16, 2000

U.K. authorities clear new ED treatment for launch

Oct. 16, 2000

NitroMed describes improved methods of treating sexual dysfunction

Oct. 13, 2000

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...